{
  "paper_metadata": {
    "pmid": "33924717",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.52C>T",
      "protein_notation": "p.Ser52Phe",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "age range 30-70, mixed sex",
        "phenotype": "familial amyloid polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "30-40 years",
            "penetrance_percentage": 20.0,
            "carriers_in_range": 5,
            "affected_in_range": 1
          },
          {
            "age_range": "41-50 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 4,
            "affected_in_range": 2
          },
          {
            "age_range": "51-70 years",
            "penetrance_percentage": 100.0,
            "carriers_in_range": 1,
            "affected_in_range": 1
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 35,
          "age_at_onset": 30,
          "age_at_diagnosis": 32,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "developed neuropathy symptoms",
          "evidence_sentence": "Patient P1 developed neuropathy symptoms at age 30."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with familial amyloid polyneuropathy",
          "evidence_sentence": "Patient P2 was diagnosed with familial amyloid polyneuropathy at age 42."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 50,
          "age_at_onset": 50,
          "age_at_diagnosis": 50,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms observed",
          "evidence_sentence": "Patient P3 remains unaffected with no symptoms observed."
        }
      ],
      "functional_data": {
        "summary": "The S52P mutation destabilizes the TTR protein structure, leading to amyloid formation.",
        "assays": [
          "stability assays",
          "amyloid fibril formation assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not reported in gnomAD.",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The S52P variant is associated with a significant risk of developing amyloidosis.",
      "key_quotes": [
        "The mutation S52P increases the ability to unfold including almost total unfolding of helix.",
        "The presence of the V30M and L55P mutations causes \u03b2-structure disruption, resulting in the generation of amyloid forms."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of TTR variants and their clinical significance.",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for the TTR gene was successfully extracted."
  }
}